亚麻籽对血压和血脂影响的临床试验进展

Q4 Nursing

中华临床营养杂志 Pub Date : 2019-08-30 DOI:10.3760/CMA.J.ISSN.1674-635X.2019.04.008

M. Ye

{"title":"亚麻籽对血压和血脂影响的临床试验进展","authors":"M. Ye","doi":"10.3760/CMA.J.ISSN.1674-635X.2019.04.008","DOIUrl":null,"url":null,"abstract":"The burden of cardiovascular disease in China is severe and keep increasing nowadays, while effective dietary management strategies play an important role in its primary prevention and treatment. Flaxseed is rich in lots of bioactive components like α-linolenic acid, lignan, linseed bioactive protein fragments and fiber, which can effectively improve a variety of heart risk factors like atherosclerosis, obesity and abnormal blood glucose, and thus has become a hot spot in researches of dietary strategies for cardiovascular diseases. As a potential heart-friendly food, cardiovascular-protective effects of flaxseed are particularly prominent in blood pressure control and lipid regulation. This article reviewed recent clinical controlled trials studying effects of flaxseed on both blood pressure and lipid profiles in different populations, and its potential hypotensive as well as lipid-lowering mechanisms, in order to lay a solid foundation for further studies. \n \n \nKey words: \nFlaxseed; Blood pressure; Blood Lipids","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"27 1","pages":"247-250"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Progress of clinical trials about effects of flaxseed in blood pressure and lipid profiles\",\"authors\":\"M. Ye\",\"doi\":\"10.3760/CMA.J.ISSN.1674-635X.2019.04.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The burden of cardiovascular disease in China is severe and keep increasing nowadays, while effective dietary management strategies play an important role in its primary prevention and treatment. Flaxseed is rich in lots of bioactive components like α-linolenic acid, lignan, linseed bioactive protein fragments and fiber, which can effectively improve a variety of heart risk factors like atherosclerosis, obesity and abnormal blood glucose, and thus has become a hot spot in researches of dietary strategies for cardiovascular diseases. As a potential heart-friendly food, cardiovascular-protective effects of flaxseed are particularly prominent in blood pressure control and lipid regulation. This article reviewed recent clinical controlled trials studying effects of flaxseed on both blood pressure and lipid profiles in different populations, and its potential hypotensive as well as lipid-lowering mechanisms, in order to lay a solid foundation for further studies. \\n \\n \\nKey words: \\nFlaxseed; Blood pressure; Blood Lipids\",\"PeriodicalId\":9877,\"journal\":{\"name\":\"中华临床营养杂志\",\"volume\":\"27 1\",\"pages\":\"247-250\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华临床营养杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.04.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.04.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}

引用次数: 0

摘要

目前，中国心血管疾病负担严重且持续增加，有效的饮食管理策略在心血管疾病的一级预防和治疗中发挥着重要作用。亚麻籽富含α-亚麻酸、木脂素、亚麻籽生物活性蛋白片段和纤维等多种生物活性成分，可有效改善动脉粥样硬化、肥胖、血糖异常等多种心脏危险因素，已成为心血管疾病饮食策略研究的热点。作为一种潜在的有益心脏的食物，亚麻籽的心血管保护作用在控制血压和调节血脂方面尤为突出。本文综述了近年来研究亚麻籽对不同人群血压和血脂的影响及其潜在的降压和降脂机制的临床对照试验，为进一步的研究奠定基础。关键词:亚麻籽;血压;血脂

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Progress of clinical trials about effects of flaxseed in blood pressure and lipid profiles

The burden of cardiovascular disease in China is severe and keep increasing nowadays, while effective dietary management strategies play an important role in its primary prevention and treatment. Flaxseed is rich in lots of bioactive components like α-linolenic acid, lignan, linseed bioactive protein fragments and fiber, which can effectively improve a variety of heart risk factors like atherosclerosis, obesity and abnormal blood glucose, and thus has become a hot spot in researches of dietary strategies for cardiovascular diseases. As a potential heart-friendly food, cardiovascular-protective effects of flaxseed are particularly prominent in blood pressure control and lipid regulation. This article reviewed recent clinical controlled trials studying effects of flaxseed on both blood pressure and lipid profiles in different populations, and its potential hypotensive as well as lipid-lowering mechanisms, in order to lay a solid foundation for further studies. Key words: Flaxseed; Blood pressure; Blood Lipids

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

中华临床营养杂志 Nursing-Nutrition and Dietetics

CiteScore

0.20

自引率

0.00%

发文量

2282

期刊介绍： The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch. The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.